JP2023526790A5 - - Google Patents

Info

Publication number
JP2023526790A5
JP2023526790A5 JP2022569498A JP2022569498A JP2023526790A5 JP 2023526790 A5 JP2023526790 A5 JP 2023526790A5 JP 2022569498 A JP2022569498 A JP 2022569498A JP 2022569498 A JP2022569498 A JP 2022569498A JP 2023526790 A5 JP2023526790 A5 JP 2023526790A5
Authority
JP
Japan
Prior art keywords
administration
group
subject
substituted
item
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022569498A
Other languages
English (en)
Japanese (ja)
Other versions
JP7783834B2 (ja
JP2023526790A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/033495 external-priority patent/WO2021236985A1/en
Publication of JP2023526790A publication Critical patent/JP2023526790A/ja
Publication of JP2023526790A5 publication Critical patent/JP2023526790A5/ja
Application granted granted Critical
Publication of JP7783834B2 publication Critical patent/JP7783834B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022569498A 2020-05-21 2021-05-20 Tie-2の活性化物質による急性呼吸窮迫症候群の処置方法 Active JP7783834B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063028317P 2020-05-21 2020-05-21
US63/028,317 2020-05-21
PCT/US2021/033495 WO2021236985A1 (en) 2020-05-21 2021-05-20 Methods of treating acute respiratory distress syndrome with activators of tie-2

Publications (3)

Publication Number Publication Date
JP2023526790A JP2023526790A (ja) 2023-06-23
JP2023526790A5 true JP2023526790A5 (https=) 2024-05-27
JP7783834B2 JP7783834B2 (ja) 2025-12-10

Family

ID=78707586

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022569498A Active JP7783834B2 (ja) 2020-05-21 2021-05-20 Tie-2の活性化物質による急性呼吸窮迫症候群の処置方法

Country Status (7)

Country Link
US (1) US12544362B2 (https=)
EP (1) EP4153237A4 (https=)
JP (1) JP7783834B2 (https=)
CN (1) CN115666651A (https=)
AU (1) AU2021275224A1 (https=)
CA (1) CA3177415A1 (https=)
WO (1) WO2021236985A1 (https=)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2195958C1 (ru) 2002-02-19 2003-01-10 Центральный научно-исследовательский институт туберкулеза РАМН Способ лечения синдрома острого повреждения легких после расширенных оперативных вмешательств
WO2004075838A2 (en) * 2003-02-21 2004-09-10 Rikshospitalet-Radiumhospitalet Hf Method and compositions for the treatment of meconium aspiration syndrome
WO2005034929A2 (en) 2003-10-10 2005-04-21 Fibrogen, Inc. Tissue remodeling and vascularization
WO2007084136A2 (en) 2006-01-23 2007-07-26 Ony, Inc. Treatment of acute respiratory distress syndrome
DK2385763T3 (en) * 2009-01-12 2018-07-16 Aerpio Therapeutics Inc METHODS OF TREATING VASCULAR LEAK SYNDROME
US9096555B2 (en) 2009-01-12 2015-08-04 Aerpio Therapeutics, Inc. Methods for treating vascular leak syndrome
CA2909080C (en) * 2013-04-11 2022-07-26 Sunnybrook Research Institute Methods, uses and compositions of tie2 agonists
US9381212B2 (en) * 2014-01-10 2016-07-05 Mallinckrodt Hospital Products IP Limited Methods of using inhaled nitric oxide gas for treatment of acute respiratory distress syndrome in children
WO2017100796A1 (en) * 2015-12-11 2017-06-15 SINACA, Academia Modulation of globoseries glycosphingolipid synthesis and cancer biomarkers
CA3137138A1 (en) * 2019-04-18 2020-10-22 EyePoint Pharmaceuticals, Inc. Methods of treating hypertension with activators of tie-2

Similar Documents

Publication Publication Date Title
JP4968868B2 (ja) 白血球数を高めるための方法および組成物
JP2024119812A5 (https=)
JP2004508404A5 (https=)
JP2016128481A (ja) 肺高血圧症の処置のためのニトロキシル供与体
RU2005128190A (ru) Ингибиторы фактора подавления миграции макрофагов (фпм) и способы их идентификации
RU2012153164A (ru) Производные мочевины и их терапевтическое применение при лечении, среди прочего, заболеваний дыхательного пути
ES2971959T3 (es) Terlipresina para el tratamiento de la ascitis debida a cirrosis hepática administrada como una infusión continua
RU2015134581A (ru) Доноры нитроксила с улучшенным терапевтическим индексом
CN1481256A (zh) 一氧化氮的吸入
JP2025501309A5 (https=)
US12064410B2 (en) Compositions and methods for stimulating ventilatory and/or respiratory
ES2652114T3 (es) Una disolución que contiene silicato para uso en el tratamiento de melanoma
JP2025500826A5 (https=)
JP2023533162A5 (https=)
FI3565551T3 (fi) Menetelmiä bakteeri-infektioiden hoitamiseksi vaborbaktaamin ja meropeneemin yhdistelmällä
JP2024518558A5 (https=)
JP2016506417A5 (https=)
JP2023526790A5 (https=)
RU2008112181A (ru) Применение конденсированных производных имидазола для лечения заболеваний, опосредованных рецептором ccr3
JP2024540198A5 (https=)
JP2024543345A5 (https=)
Rioja et al. Cardiorespiratory and minimum alveolar concentration sparing effects of a continuous intravenous infusion of dexmedetomidine in halothane or isoflurane-anaesthetized rats
US10543187B2 (en) Compositions and methods for stimulating ventilatory and/or respiratory drive
AU2016364380B2 (en) Formulations for intravenous injection of danirixin
US20250262181A1 (en) Compositions and methods for stimulating ventilatory and/or respiratory